NUVISAN The Science CRO
Dirk Scharn is currently the Director, Head of in vitro PK at Nuvisan Pharma Services since October 2020. Prior to this role, Dirk was the Research Laboratory Head at Boehringer Ingelheim RCV GmbH & Co KG from September 2010 to October 2020. Before that, Dirk worked as a Study Director at Econ Pharma AG and as a senior scientist at Jerini AG. Dirk has a Ph.D. in Chemistry from Humboldt-Universität zu Berlin. Throughout their career, Dirk has been involved in various research and development projects in the field of DMPK, metabolite-ID, DDI, and PK/PD support for pharmaceutical compounds. Dirk's expertise includes quantitative PK/PD projections, process improvement, setting up new assays, and working with CROs and clients.
This person is not in the org chart
NUVISAN The Science CRO
1 followers
Founded in Europe with more than 40 years of experience, NUVISAN is a fully integrated contract research and development, and manufacturing organization (CRO/CDMO) that offers unique, high-quality, and tailored integrated solutions along the drug discovery and development value chain. With more than 1.000 employees distributed over six locations in Germany and France including our drug discovery hub in Berlin as well as with local experts situated in Latin America, NUVISAN is pleased to offer the following portfolio of services: • Drug discovery & research - Discovery pharmacology - Discovery bioscience - Screening - Life science chemistry - Translation research - Digital life science - Toxicology - DMPK • Non-clinical studies • Pharmaceutical analysis • Topical formulation development • Chemical development with GMP manufacturing (3-10kg) • Bioanalytical labs • GMP manufacturing (up to 50Kg) • Clinical trial supplies • Phase 1 and 2 clinical studies and beyond Our services can be provided as stand-alone or integrated solutions and can be customized to your project. Email us at hello@nuvisan.com for more.